Skip to main content
OpenTrials

Clinical trial condition

EGFR Uncommon Mutations

Explore clinical trials studying EGFR Uncommon Mutations. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

EGFR Uncommon Mutations trial results

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

NCT07185997

Conditions
Advanced Non-Small-Cell Lung Cancer, Bronchial Diseases, Bronchial Neoplasms, +14 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Kaiser Permanente Medical Center Vallejo, California, United States
View all 118 locations
View Trial Details

Related conditions